- Nachrichtendetail
-
08.05.2024 08:09:52 - Media Release: Sensirion product announcement: miniature liquid flow sensor platform for subcutaneous drug delivery
===
Sensirion Holding AG / Key word(s): Miscellaneous
Media Release: Sensirion product announcement: miniature liquid flow sensor platform for subcutaneous drug delivery
2024-05-08 / 08:08 CET/CEST
Media Release
08.05.2024, Sensirion AG, 8712 Stäfa, Schweiz
Sensirion product announcement: miniature liquid flow sensor platform for subcutaneous drug delivery
In the changing landscape of the healthcare industry, Sensirion's SLD3x series contributes to the improvement of
subcutaneous drug delivery with miniature, and highly accurate digital liquid flow sensors. Customizable solutions
ensure optimal dosing and enhanced patient safety for various subcutaneous therapies.
Stäfa, Switzerland - The healthcare industry has undergone a significant transformation in recent years, with an
increasing focus on patient and home care. This shift has been mirrored in the field of drug administration, with a
decrease in hospital stays for certain treatments. The transition from intravenous to subcutaneous injections using
large volume injectors (LVIs) has been a key driver of this change.
LVIs are wearable devices that enable continuous subcutaneous drug delivery. They reduce pressure on clinical staff,
save costs, and improve patient comfort. Some LVIs require precise dosing of the delivered drug, which in turn requires
the pump to be controlled by a flow sensor. Moreover, bubbles, empty lines, occlusion detection, and drug delivery
confirmation are desirable to improve patient safety and the regulatory compliance of the device.
To meet these needs, Sensirion is developing the SLD3x platform - a series of digital liquid flow sensors to combine
accurate flow measurement, miniature size, and compatibility with several therapies. This makes it the ideal solution
for medical devices manufactured in large quantities, where an accurate, disposable liquid flow sensor is required.
While flow measurement is at the heart of the SLD3x platform, it also provides a stream of data that can be used to
detect occlusions, identify in-line air bubbles, flag up pump malfunctions and measure liquid temperature.
"The SLD3x series features models with maximum flow rates ranging from 100 µl/min to 5 ml/min to meet the varying
dosing requirements of different drugs and treatment protocols. We are happy to discuss the customization of sensors to
meet the unique needs of specific therapies." says Dr. Konrad Domanski, Product Director Liquid Flow Sensors at
Sensirion.
For more information, please visit our product page or join our live webinar on May 23^rd^.
SLD3x series at a glance:
About Sensirion - Experts for Environmental and Flow Sensor Solutions
Sensirion is one of the world's leading developers and manufacturers of sensors and sensor solutions that improve
efficiency, health, safety, and comfort. Founded in 1998, Sensirion now employs around 1'200 people at its headquarters
in Stäfa, Switzerland and in numerous international subsidiaries. Sensirion sensors can be used to measure a wide range
of environmental parameters and flow rates precisely and reliably. The company's aim is to make the world smarter with
advanced sensor technology. As a pioneer in innovation, Sensirion develops solutions for the specific needs of
customers and partners from the automotive, industrial, medical technology and consumer electronics markets, as well as
high-quality products for cost-efficient mass production. More information and current key figures are available at
www.sensirion.com.
Additional features:
Laubisrütistrasse 50
8712 Stäfa
Switzerland
End of News EQS News Service
===
1898195 2024-05-08 CET/CEST
Image link: https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=show_t_gif&application_id=1898195&application_name=news
END) Dow Jones Newswires
May 08, 2024 02:09 ET (06:09 GMT)
Sensirion Holding AG / Key word(s): Miscellaneous
Media Release: Sensirion product announcement: miniature liquid flow sensor platform for subcutaneous drug delivery
2024-05-08 / 08:08 CET/CEST
Media Release
08.05.2024, Sensirion AG, 8712 Stäfa, Schweiz
Sensirion product announcement: miniature liquid flow sensor platform for subcutaneous drug delivery
In the changing landscape of the healthcare industry, Sensirion's SLD3x series contributes to the improvement of
subcutaneous drug delivery with miniature, and highly accurate digital liquid flow sensors. Customizable solutions
ensure optimal dosing and enhanced patient safety for various subcutaneous therapies.
Stäfa, Switzerland - The healthcare industry has undergone a significant transformation in recent years, with an
increasing focus on patient and home care. This shift has been mirrored in the field of drug administration, with a
decrease in hospital stays for certain treatments. The transition from intravenous to subcutaneous injections using
large volume injectors (LVIs) has been a key driver of this change.
LVIs are wearable devices that enable continuous subcutaneous drug delivery. They reduce pressure on clinical staff,
save costs, and improve patient comfort. Some LVIs require precise dosing of the delivered drug, which in turn requires
the pump to be controlled by a flow sensor. Moreover, bubbles, empty lines, occlusion detection, and drug delivery
confirmation are desirable to improve patient safety and the regulatory compliance of the device.
To meet these needs, Sensirion is developing the SLD3x platform - a series of digital liquid flow sensors to combine
accurate flow measurement, miniature size, and compatibility with several therapies. This makes it the ideal solution
for medical devices manufactured in large quantities, where an accurate, disposable liquid flow sensor is required.
While flow measurement is at the heart of the SLD3x platform, it also provides a stream of data that can be used to
detect occlusions, identify in-line air bubbles, flag up pump malfunctions and measure liquid temperature.
"The SLD3x series features models with maximum flow rates ranging from 100 µl/min to 5 ml/min to meet the varying
dosing requirements of different drugs and treatment protocols. We are happy to discuss the customization of sensors to
meet the unique needs of specific therapies." says Dr. Konrad Domanski, Product Director Liquid Flow Sensors at
Sensirion.
For more information, please visit our product page or join our live webinar on May 23^rd^.
SLD3x series at a glance:
Full scale flow rate (H[2]O) 5 ml/min Accuracy (H[2]O) 5 % Maximum operating pressure 3 bar Fluidic connector ports Downmount Supply voltage 3.2 - 3.8 V Size (LxWxH) 12 x 12 x 3.2 mm^3
About Sensirion - Experts for Environmental and Flow Sensor Solutions
Sensirion is one of the world's leading developers and manufacturers of sensors and sensor solutions that improve
efficiency, health, safety, and comfort. Founded in 1998, Sensirion now employs around 1'200 people at its headquarters
in Stäfa, Switzerland and in numerous international subsidiaries. Sensirion sensors can be used to measure a wide range
of environmental parameters and flow rates precisely and reliably. The company's aim is to make the world smarter with
advanced sensor technology. As a pioneer in innovation, Sensirion develops solutions for the specific needs of
customers and partners from the automotive, industrial, medical technology and consumer electronics markets, as well as
high-quality products for cost-efficient mass production. More information and current key figures are available at
www.sensirion.com.
Additional features:
File: Sensirion SLD3x Platform End of Media Release Language: English Company: Sensirion Holding AG
Laubisrütistrasse 50
8712 Stäfa
Switzerland
Phone: +41 44 306 40 00 Fax: +41 44 306 49 06 Internet: www.sensirion.com ISIN: CH0406705126 Valor: A2JGBW Listed: Regulated Unofficial Market in Berlin, Frankfurt, Munich, Stuttgart; SIX Swiss Exchange EQS News ID: 1898195
End of News EQS News Service
===
1898195 2024-05-08 CET/CEST
Image link: https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=show_t_gif&application_id=1898195&application_name=news
END) Dow Jones Newswires
May 08, 2024 02:09 ET (06:09 GMT)
